Catalyst Wire Dossier Catalyst Wire Dossier

iCP-NI

· Cellivery Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iCP-NI, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects [Phase 1]

See pricing